185 related articles for article (PubMed ID: 6330174)
1. Pharmacology and inotropic potential of forskolin in the human heart.
Bristow MR; Ginsburg R; Strosberg A; Montgomery W; Minobe W
J Clin Invest; 1984 Jul; 74(1):212-23. PubMed ID: 6330174
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.
Calderone A; Bouvier M; Li K; Juneau C; de Champlain J; Rouleau JL
Circ Res; 1991 Aug; 69(2):332-43. PubMed ID: 1650296
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
Fan TH; Liang CS; Kawashima S; Banerjee SP
Eur J Pharmacol; 1987 Aug; 140(2):123-32. PubMed ID: 2822436
[TBL] [Abstract][Full Text] [Related]
4. The positive inotropic-acting forskolin, a potent adenylate cyclase activator.
Metzger H; Lindner E
Arzneimittelforschung; 1981; 31(8):1248-50. PubMed ID: 7197529
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass.
Dupuis JY; Li K; Calderone A; Gosselin H; Yang XP; Anand-Srivastava MB; Teijeira J; Rouleau JL
Cardiovasc Res; 1997 Nov; 36(2):223-35. PubMed ID: 9463634
[TBL] [Abstract][Full Text] [Related]
6. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
Böhm M; Beuckelmann D; Brown L; Feiler G; Lorenz B; Näbauer M; Kemkes B; Erdmann E
Eur Heart J; 1988 Aug; 9(8):844-52. PubMed ID: 2460351
[TBL] [Abstract][Full Text] [Related]
7. Neurally mediated cardiac effects of forskolin in conscious dogs.
Iwase M; Ishikawa Y; Shen YT; Shannon RP; Sato N; Ganguly PK; Eki T; Vatner DF; Vatner SF
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1473-82. PubMed ID: 8897942
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine.
Yoneyama M; Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Hashimoto K
Circ J; 2002 Dec; 66(12):1150-4. PubMed ID: 12499623
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.
Hussain RI; Afzal F; Mørk HK; Aronsen JM; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
Br J Pharmacol; 2011 Feb; 162(4):908-16. PubMed ID: 21039419
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig.
Waldeck B; Widmark E
Eur J Pharmacol; 1985 Jun; 112(3):349-53. PubMed ID: 4040470
[TBL] [Abstract][Full Text] [Related]
11. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
Näbauer M; Böhm M; Brown L; Diet F; Eichhorn M; Kemkes B; Pieske B; Erdmann E
Eur J Clin Invest; 1988 Dec; 18(6):600-6. PubMed ID: 2465159
[TBL] [Abstract][Full Text] [Related]
12. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.
Bristow MR; Ginsburg R; Minobe W; Cubicciotti RS; Sageman WS; Lurie K; Billingham ME; Harrison DC; Stinson EB
N Engl J Med; 1982 Jul; 307(4):205-11. PubMed ID: 6283349
[TBL] [Abstract][Full Text] [Related]
13. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J
Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864
[TBL] [Abstract][Full Text] [Related]
14. The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Hussain RI; Aronsen JM; Afzal F; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
J Mol Cell Cardiol; 2013 Mar; 56():129-38. PubMed ID: 23220156
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
Ray A; MacLeod KM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
[TBL] [Abstract][Full Text] [Related]
16. Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure.
Reithmann C; Werdan K
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):138-44. PubMed ID: 2471084
[TBL] [Abstract][Full Text] [Related]
17. Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice.
Uhl S; Mathar I; Vennekens R; Freichel M
J Mol Cell Cardiol; 2014 Sep; 74():307-17. PubMed ID: 24972051
[TBL] [Abstract][Full Text] [Related]
18. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties.
de Souza NJ; Dohadwalla AN; Reden J
Med Res Rev; 1983; 3(2):201-19. PubMed ID: 6345959
[No Abstract] [Full Text] [Related]
19. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
[TBL] [Abstract][Full Text] [Related]
20. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.
Tanaka H; Shigenobu K
Br J Pharmacol; 1990 May; 100(1):138-42. PubMed ID: 2164856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
